CA Stock MarketDetailed Quotes

CRDL Cardiol Therapeutics Inc

Watchlist
  • 2.650
  • -0.040-1.49%
15min DelayMarket Closed Oct 18 16:00 ET
210.90MMarket Cap-6022P/E (TTM)

Cardiol Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
22.59%7.74M
7.95%8.41M
-27.94%29.79M
-11.72%8.03M
-42.09%7.66M
-31.60%6.31M
-20.46%7.79M
6.69%41.34M
-30.56%9.1M
30.07%13.22M
Selling and administrative expenses
77.47%5.03M
38.93%5.08M
-30.45%15.56M
14.71%3.99M
-37.53%5.08M
-41.24%2.84M
-38.42%3.66M
-19.73%22.37M
-63.67%3.48M
7.39%8.13M
-General and administrative expense
77.47%5.03M
38.93%5.08M
-30.45%15.56M
14.71%3.99M
-37.53%5.08M
-41.24%2.84M
-38.42%3.66M
-19.73%22.37M
-63.67%3.48M
7.39%8.13M
Research and development costs
-22.12%2.71M
-19.50%3.32M
-24.99%14.22M
-28.08%4.04M
-49.37%2.58M
-21.05%3.48M
7.28%4.13M
74.44%18.96M
59.25%5.62M
96.34%5.09M
Operating profit
-22.59%-7.74M
-7.95%-8.41M
27.94%-29.79M
11.72%-8.03M
42.09%-7.66M
31.60%-6.31M
20.46%-7.79M
-6.91%-41.34M
30.56%-9.1M
-30.07%-13.22M
Net non-operating interest income (expenses)
-41.86%307.41K
-30.89%377.29K
64.71%2.04M
-23.32%448.3K
32.41%515.54K
176.32%528.7K
654.97%545.93K
1,067.57%1.24M
2,005.55%584.65K
983.60%389.34K
Non-operating interest income
-41.86%307.41K
-30.89%377.29K
64.71%2.04M
-23.32%448.3K
32.41%515.54K
176.32%528.7K
654.97%545.93K
1,067.57%1.24M
2,005.55%584.65K
983.60%389.34K
Other net income (expenses)
150.01%843.06K
-863.19%-1.15M
-104.16%-381.25K
-105.68%-56.49K
-75.09%1.21M
-166.07%-1.69M
-80.20%150.87K
32.47%9.17M
-85.39%995.35K
2,131.99%4.86M
Gain on sale of security
150.01%843.06K
-881.89%-1.18M
-105.90%-530.99K
-105.68%-56.49K
-77.41%1.06M
-166.07%-1.69M
-80.20%150.87K
32.24%9M
-85.35%995.35K
3,667.16%4.69M
Other non-operating income (expenses)
----
--28.22K
-8.94%149.74K
--0
-8.94%149.74K
----
----
46.52%164.44K
--0
76.68%164.44K
Income before tax
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
19.56%-7.97M
Income tax
Earnings from equity interest net of tax
Net income
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
19.56%-7.97M
Net income continuous operations
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
19.56%-7.97M
Noncontrolling interests
Net income attributable to the company
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
19.56%-7.97M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
11.79%-6.59M
-29.49%-9.18M
9.06%-28.13M
-1.62%-7.64M
25.61%-5.93M
-15.14%-7.47M
20.83%-7.09M
2.24%-30.93M
-20.10%-7.52M
19.56%-7.97M
Diluted earnings per share
16.67%-0.1
-27.27%-0.14
10.20%-0.44
-9.09%-0.12
30.77%-0.09
-20.00%-0.12
21.43%-0.11
32.88%-0.49
-37.50%-0.11
43.48%-0.13
Basic earnings per share
16.67%-0.1
-27.27%-0.14
10.20%-0.44
-9.09%-0.12
30.77%-0.09
-20.00%-0.12
21.43%-0.11
32.88%-0.49
-37.50%-0.11
43.48%-0.13
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 22.59%7.74M7.95%8.41M-27.94%29.79M-11.72%8.03M-42.09%7.66M-31.60%6.31M-20.46%7.79M6.69%41.34M-30.56%9.1M30.07%13.22M
Selling and administrative expenses 77.47%5.03M38.93%5.08M-30.45%15.56M14.71%3.99M-37.53%5.08M-41.24%2.84M-38.42%3.66M-19.73%22.37M-63.67%3.48M7.39%8.13M
-General and administrative expense 77.47%5.03M38.93%5.08M-30.45%15.56M14.71%3.99M-37.53%5.08M-41.24%2.84M-38.42%3.66M-19.73%22.37M-63.67%3.48M7.39%8.13M
Research and development costs -22.12%2.71M-19.50%3.32M-24.99%14.22M-28.08%4.04M-49.37%2.58M-21.05%3.48M7.28%4.13M74.44%18.96M59.25%5.62M96.34%5.09M
Operating profit -22.59%-7.74M-7.95%-8.41M27.94%-29.79M11.72%-8.03M42.09%-7.66M31.60%-6.31M20.46%-7.79M-6.91%-41.34M30.56%-9.1M-30.07%-13.22M
Net non-operating interest income (expenses) -41.86%307.41K-30.89%377.29K64.71%2.04M-23.32%448.3K32.41%515.54K176.32%528.7K654.97%545.93K1,067.57%1.24M2,005.55%584.65K983.60%389.34K
Non-operating interest income -41.86%307.41K-30.89%377.29K64.71%2.04M-23.32%448.3K32.41%515.54K176.32%528.7K654.97%545.93K1,067.57%1.24M2,005.55%584.65K983.60%389.34K
Other net income (expenses) 150.01%843.06K-863.19%-1.15M-104.16%-381.25K-105.68%-56.49K-75.09%1.21M-166.07%-1.69M-80.20%150.87K32.47%9.17M-85.39%995.35K2,131.99%4.86M
Gain on sale of security 150.01%843.06K-881.89%-1.18M-105.90%-530.99K-105.68%-56.49K-77.41%1.06M-166.07%-1.69M-80.20%150.87K32.24%9M-85.35%995.35K3,667.16%4.69M
Other non-operating income (expenses) ------28.22K-8.94%149.74K--0-8.94%149.74K--------46.52%164.44K--076.68%164.44K
Income before tax 11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M19.56%-7.97M
Income tax
Earnings from equity interest net of tax
Net income 11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M19.56%-7.97M
Net income continuous operations 11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M19.56%-7.97M
Noncontrolling interests
Net income attributable to the company 11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M19.56%-7.97M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 11.79%-6.59M-29.49%-9.18M9.06%-28.13M-1.62%-7.64M25.61%-5.93M-15.14%-7.47M20.83%-7.09M2.24%-30.93M-20.10%-7.52M19.56%-7.97M
Diluted earnings per share 16.67%-0.1-27.27%-0.1410.20%-0.44-9.09%-0.1230.77%-0.09-20.00%-0.1221.43%-0.1132.88%-0.49-37.50%-0.1143.48%-0.13
Basic earnings per share 16.67%-0.1-27.27%-0.1410.20%-0.44-9.09%-0.1230.77%-0.09-20.00%-0.1221.43%-0.1132.88%-0.49-37.50%-0.1143.48%-0.13
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data